Ben Z. Stanger
Affiliations: | Cell and Molecular Biology | University of Pennsylvania, Philadelphia, PA, United States |
Area:
Molecular Biology, Cell Biology, Human DevelopmentGoogle:
"Ben Stanger"Children
Sign in to add trainee| Yiwei Zong | grad student | 2011 | Penn |
| Zhewei Shen | grad student | 2014 | Penn |
| Ravikanth Maddipati | post-doc | Penn (Chemistry Tree) |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Brown BA, Myers PJ, Adair SJ, et al. (2024) A histone methylation-MAPK signaling axis drives durable epithelial-mesenchymal transition in hypoxic pancreatic cancer. Cancer Research |
| Katsuda T, Sussman JH, Ito K, et al. (2024) Cellular reprogramming in vivo initiated by SOX4 pioneer factor activity. Nature Communications. 15: 1761 |
| Kim IK, Diamond MS, Yuan S, et al. (2024) Plasticity-induced repression of Irf6 underlies acquired resistance to cancer immunotherapy in pancreatic ductal adenocarcinoma. Nature Communications. 15: 1532 |
| Pitarresi JR, Stanger BZ. (2023) Cellular Origins and Lineage Plasticity in Cancer. Cold Spring Harbor Perspectives in Medicine |
| Sussman JH, Stanger BZ. (2023) Digging deeper into the early steps of cancer progression. Trends in Cancer |
| Kim IK, Diamond M, Yuan S, et al. (2023) Plasticity-induced repression of Irf6 underlies acquired resistance to cancer immunotherapy. Research Square |
| Bianchi A, De Castro Silva I, Deshpande NU, et al. (2023) Cell-autonomous Cxcl1 sustains tolerogenic circuitries and stromal inflammation via neutrophil-derived TNF in pancreatic cancer. Cancer Discovery |
| Katsuda T, Sussman J, Ito K, et al. (2023) Physiological reprogramming mediated by Sox4 pioneer factor activity. Biorxiv : the Preprint Server For Biology |
| Halbrook CJ, Thurston G, Boyer S, et al. (2022) Differential integrated stress response and asparagine production drive symbiosis and therapy resistance of pancreatic adenocarcinoma cells. Nature Cancer. 3: 1386-1403 |
| McBrearty N, Cho C, Chen J, et al. (2022) Tumor suppressive and immune-stimulating roles of cholesterol 25-hydroxylase in pancreatic cancer cells. Molecular Cancer Research : McR |